American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis — 2016
Top Cited Papers
- 1 September 2016
- journal article
- research article
- Published by Elsevier BV in Endocrine Practice
- Vol. 22, 1-42
- https://doi.org/10.4158/ep161435.gl
Abstract
No abstract availableThis publication has 232 references indexed in Scilit:
- The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)Journal of Bone and Mineral Research, 2011
- Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fracturesJournal of Bone and Mineral Research, 2011
- WHO absolute fracture risk models (FRAX): Do clinical risk factors improve fracture prediction in older women without osteoporosis?Journal of Bone and Mineral Research, 2011
- Oral bisphosphonates and risk of subtrochanteric or diaphyseal femur fractures in a population-based cohortJournal of Bone and Mineral Research, 2010
- Exposure to Oral Bisphosphonates and Risk of Esophageal CancerJAMA, 2010
- Cost-effective osteoporosis treatment thresholds: the United States perspectiveOsteoporosis International, 2008
- Vitamin D Supplementation and Total MortalityA Meta-analysis of Randomized Controlled TrialsArchives of Internal Medicine, 2007
- Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease OutcomesThe NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 TrialJAMA, 2006
- Effect of Vitamin D on FallsJAMA, 2004
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002